BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34031711)

  • 1. Favorable Outcomes of Neoadjuvant Chemotherapy and Limited Para-Aortic Lymph Node Dissection for Advanced Gastric Cancer with Para-aortic Lymph Node Metastasis.
    Ri M; Ohashi M; Eto K; Ishizuka N; Atsumi S; Makuuchi R; Ida S; Kumagai K; Sano T; Nunobe S
    World J Surg; 2021 Sep; 45(9):2849-2859. PubMed ID: 34031711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative chemotherapy combined with para-aortic lymph node dissection has clinical value in the treatment of gastric cancer with para-aortic lymph node metastases.
    Yu P; Hu C; Wang Y; Bao Z; Zhang R; Cao M; Zhang Y; Cheng X; Xu Z
    BMC Surg; 2022 Nov; 22(1):401. PubMed ID: 36404297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A good surgical field for para-aortic nodal dissection in gastric cancer by the Cattell-Braasch maneuver.
    Akita M; Maeda E; Ishida R; Morikawa T; Nishimura T; Abe K; Kozuki A; Tanaka T; Kaneda K
    Langenbecks Arch Surg; 2022 Nov; 407(7):3141-3146. PubMed ID: 35978050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in patients who received paraaortic lymph node dissection for locally advanced gastric cancer with extensive lymph node metastasis.
    Hikage M; Fujiya K; Kamiya S; Tanizawa Y; Bando E; Notsu A; Terashima M
    Langenbecks Arch Surg; 2022 May; 407(3):1027-1037. PubMed ID: 35022832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three Cases of No. 16 Lymph Node Metastasis-Positive Gastric Cancer Successfully Treated with Chemotherapy and Para-Aortic Lymph Node Dissection].
    Tamaki S; Taniguchi K; Katsuragawa H; Hataji K; Okamoto F; Hayashi T; Ishii M; Tateno Y; Kanada Y; Yagi M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2048-2051. PubMed ID: 35045489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
    Wada T; Yoshikawa T; Sekine S; Kamiya A; Hayashi T; Otsuki S; Yamagata Y; Katai H
    Eur J Surg Oncol; 2022 Feb; 48(2):333-338. PubMed ID: 34284903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Dissection after Neoadjuvant Chemotherapy].
    Ogawa T; Choda Y; Ninomiya M; Nagai Y; Mimura N; Miyake S; Ishida M; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2205-2207. PubMed ID: 28133270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer.
    Tanaka K; Yano M; Motoori M; Doki Y; Kishi K; Miyashiro I; Shingai T; Gotoh K; Noura S; Takahashi H; Ohue M; Yamada T; Ohigashi H; Ishikawa O
    Dis Esophagus; 2012 Feb; 25(2):146-52. PubMed ID: 21762280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes?
    Tokunaga M; Ohyama S; Hiki N; Fukunaga T; Aikou S; Yamaguchi T
    Ann Surg Oncol; 2010 Aug; 17(8):2031-6. PubMed ID: 20182811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of para-aortic lymph node metastasis from colorectal cancer in highly selected patients undergoing para-aortic lymph node dissection.
    Emoto S; Fukunaga Y; Takamatsu M; Kawachi H; Sano S; Tominaga T; Mukai T; Yamaguchi T; Nagasaki T; Akiyoshi T; Konishi T; Nagayama S; Ueno M
    Surg Today; 2024 Apr; 54(4):356-366. PubMed ID: 37648781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidates for curative resection in advanced gastric cancer patients who had equivocal para-aortic lymph node metastasis on computed tomographic scan.
    Lee JH; Paik YH; Lee JS; Song HJ; Ryu KW; Kim CG; Park SR; Kook MC; Kim YW; Bae JM
    Ann Surg Oncol; 2006 Sep; 13(9):1163-7. PubMed ID: 16952027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-Term Survival of a Patient with Para-Aortic Lymph Node Recurrence Who Underwent Lymph Node Dissection and Received Chemotherapy Following Curative Gastrectomy].
    Noro H; Hirao T; Teranishi R; Shimura Y; Todo M; Ohashi T; Osawa H; Sakai K; Yasumasa K; Iwasaki T; Hatanaka N; Yamasaki Y
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):745-747. PubMed ID: 31164522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer.
    Nakai N; Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Numata M; Furutani A
    Int J Colorectal Dis; 2017 Jul; 32(7):999-1007. PubMed ID: 28382511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
    Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
    J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
    Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
    Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Selection for Resection of Synchronous Para-Aortic Lymph Node Metastases in Colorectal Cancer.
    Yamada K; Tsukamoto S; Ochiai H; Shida D; Kanemitsu Y
    Dig Surg; 2019; 36(5):369-375. PubMed ID: 30045044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors and Recurrence Pattern of Far-advanced Gastric Cancer with Pathologically-positive Para-aortic Lymph Nodes.
    Kaito A; Kinoshita T; Tokunaga M; Sunagawa H; Watanabe M; Sugita S; Tonouchi A; Sato R; Abe I; Akimoto T
    Anticancer Res; 2017 Jul; 37(7):3685-3692. PubMed ID: 28668861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
    Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
    World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic curative para-aortic lymph node dissection via INfra-mesocolon for gastric cancer: Robotic CAVING approach.
    Ojima T; Hayata K; Kitadani J; Yamaue H
    Surg Oncol; 2021 Dec; 39():101658. PubMed ID: 34624690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of para-aortic nodal dissection for locoregionally advanced gastric cancer with 1-3 involved para-aortic nodes.
    Zhang C; He Y; Schwarz RE; Smith DD; Wang L; Liu F; Zhan W
    Chin Med J (Engl); 2014; 127(3):435-41. PubMed ID: 24451947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.